Describe factors associated with the underrecognition of MDD among older adults and the importance of managing the disorder in these patients Assess the ongoing challenges of managing MDD in older adults, including age-related biological changes and complex comorbidities Evaluate the latest clinical and real-world evidence associated with conventional antidepressants and newer multimodal agents for older patients with MDD Implement patient-centered treatment planning strategies for older adults with MDD, including shared decision-making with patients and caregivers
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
CME included with membership · $99–598/yr
| New Membership – Standard | $349/yr |
| New Membership – Standard (2-year) | $598/yr |
| New Membership – Military/VA | $259/yr |
| New Membership – Student/Resident | $149/yr |
| Renewal Membership – Standard | $249/yr |
| Renewal Membership – Standard (2-year) | $478/yr |
+27 more tiers
Collected from the provider’s public pages · source
Specialties served/covered
- Child & Adolescent Psychiatry
- Clinical Informatics
- Communication & Shared Decision-Making
- General & Adult Psychiatry
- General Surgery
- Interventional Radiology
- Mood & Anxiety Disorders
- Neurology
- Neuroradiology
- Nuclear Medicine
- Pain Medicine
- Pediatric Neurology
- Practice Management & Ethics
- Psychopharmacology
- Psychotic Disorders
- Sleep Medicine
- Cross-Specialty
- Medical Subspecialties
- Neurology
- Pain & Palliative
- Psychiatry
- Radiology
- Surgery
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- Credit · Up to 1.25 credits
- MOC · Up to 1.25 points
- Commercial Support
-
ReleasedOct 30, 2025
-
Last day to claim creditOct 31, 2026 3 weeks left
-
HMP Education Aiming Higher in MDD: Practical Strategies and Novel Monotherapies to Improve Outcomes
-
HMP Education Time to Change the Target: Optimal Use of Glutamatergic Antidepressants in Treatment-Resistant Depression
-
HMP Education Novel Strategies for Treatment-Resistant Depression : Understanding the Utility of Glutamatergic Antidepressants
-
American Medical Association Treating Older Adults: Practical Guidance for Pain Management
-
Med Learning Group Optimizing Outcomes in nAMD: Evidence-Based Selection, Sequencing, and Durability Strategies with Next-Generation Anti-VEGF Therapies
-
Obesity Medicine Association Psychedelics for the Treatment of Obesity: Review of The Evidence and a Call to Action (Recorded Webinar)
